Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Aspartame 💬[1] Aspartame (L-Aspartyl-L-phenylalanine methyl ester)[0] [2] TAS1R2,
TAS1R3 💬 		[2] Carbohydrate digestion and absorption, Taste transduction 💬-
2 Levodopa 💬[1] Levodopa (Dihydroxy-L-phenylalanine)[9] Carbidopa-Levodopa; DUODOPA; Inbrija; L-DOPA; Levodopa; PARCOPA; SINEMET; SINEMET CR; Stalevo[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[6] 6, 17, 90, 140, 164, 201 💬
3 Melphalan 💬[1] Melphalan (p-Di-amino-L-phenylalanine)[3] ALKERAN; Melphalan; Melphalan Hydrochloride--[15] 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬
4 Phenylalanine 💬
(Phenylalanine (USP/INN), L-Phenylalanine (JP18))		[1] Phenylalanine (L-Phenylalanine)[1] Phenylalanine--[1] 240 💬
5 Tyrosine 💬[1] Tyrosine (4-hydroxy-L-phenylalanine)[4] Alanine; L-Tyrosine; Propanoic acid; Tyrosine--[4] 6, 86, 111, 298 💬